Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
1.262
-0.138 (-9.86%)
At close: Dec 5, 2025
45.06%
Market Cap 181.26M
Revenue (ttm) n/a
Net Income (ttm) -6.60M
Shares Out 143.63M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,650,079
Average Volume 5,139,405
Open 1.400
Previous Close 1.400
Day's Range 1.252 - 1.400
52-Week Range 0.480 - 1.852
Beta 1.60
RSI 61.04
Earnings Date Nov 9, 2025

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 10
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.